Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Glennon

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of the American College of Cardiology|March 1, 2005
Definition of failed lysis may have influenced outcome in the MERLIN trialFaizel Osman, Amer Chit, Peter E Glennon
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 2, 2008
Pacemaker-mediated dermatitisYogesh Raja, Purushottam V Desai, Peter E Glennon
Circulation|September 19, 2007
Images in cardiovascular medicine. Subacute massive pulmonary embolism diagnosed by transesophageal echocardiographyRajinder S Bilku, Peter E Glennon, Martin Been
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 30, 2002
Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidancePeter E Glennon, Peter L Weissberg, Sarah C Clarke, et al.
International Journal of Cardiology|October 24, 2007
Presentation of an embolised Amplatzer septal occluder to the main pulmonary artery 2 years after implantationDimitrios N Lysitsas, Ben Wrigley, Pritwith Banerjee, et al.
Clinical Science (London, England : 1979)|November 4, 2022
Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in miceHajed O Alharbi, Michelle A Hardyman, Joshua J Cull, et al.
Clinical Science (London, England : 1979)|July 23, 2021
The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertensionDaniel N Meijles, Joshua J Cull, Susanna T E Cooper, et al.
Circulation|March 3, 2010
Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategiesDavid Hildick-Smith, Adam J de Belder, Nina Cooter, et al.
The Biochemical Journal|February 11, 2022
Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivoAngela Clerk, Daniel N Meijles, Michelle A Hardyman, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the American College of Cardiology|March 1, 2005
Definition of failed lysis may have influenced outcome in the MERLIN trialFaizel Osman, Amer Chit, Peter E Glennon
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 2, 2008
Pacemaker-mediated dermatitisYogesh Raja, Purushottam V Desai, Peter E Glennon
Circulation|September 19, 2007
Images in cardiovascular medicine. Subacute massive pulmonary embolism diagnosed by transesophageal echocardiographyRajinder S Bilku, Peter E Glennon, Martin Been
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 30, 2002
Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidancePeter E Glennon, Peter L Weissberg, Sarah C Clarke, et al.
International Journal of Cardiology|October 24, 2007
Presentation of an embolised Amplatzer septal occluder to the main pulmonary artery 2 years after implantationDimitrios N Lysitsas, Ben Wrigley, Pritwith Banerjee, et al.
Clinical Science (London, England : 1979)|November 4, 2022
Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in miceHajed O Alharbi, Michelle A Hardyman, Joshua J Cull, et al.
Clinical Science (London, England : 1979)|July 23, 2021
The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertensionDaniel N Meijles, Joshua J Cull, Susanna T E Cooper, et al.
Circulation|March 3, 2010
Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategiesDavid Hildick-Smith, Adam J de Belder, Nina Cooter, et al.
The Biochemical Journal|February 11, 2022
Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivoAngela Clerk, Daniel N Meijles, Michelle A Hardyman, et al.
Pageof 1